honokiol has been researched along with Peritoneal Carcinomatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbiser, JL; Chiu, CS; Hsieh, MS; Hsing, HY; Jan, YJ; Lai, DW; Lin, WY; Sheu, ML; Tsai, CH; Tsai, SC; Wu, SM | 1 |
| Chiu, CS; Lai, DW; Lan, KH; Pan, HC; Shen, CC; Sheu, ML; Wang, KB; Wu, SM | 1 |
2 other study(ies) available for honokiol and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; beta Catenin; Biphenyl Compounds; Calpain; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase 2; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Lignans; Male; Melanoma; Mice, Inbred BALB C; Mice, Nude; Microphthalmia-Associated Transcription Factor; Peritoneal Neoplasms; Skin Neoplasms; Transcription Factor CHOP; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2019 |
Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Immunoprecipitation; Lignans; Luciferases; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred BALB C; Mice, Nude; Peritoneal Neoplasms; Phytotherapy; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured | 2013 |